| A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia MD Cappellini, V Viprakasit, AT Taher, P Georgiev, KHM Kuo, T Coates, ... New England Journal of Medicine 382 (13), 1219-1231, 2020 | 243 | 2020 |
| Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis M Sarigianni, A Liakos, E Vlachaki, P Paschos, E Athanasiadou, ... Clinical gastroenterology and hepatology 13 (1), 55-63. e5, 2015 | 79 | 2015 |
| Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis J Kountouras, SA Polyzos, M Doulberis, C Zeglinas, F Artemaki, ... Metabolism 87, 18-24, 2018 | 65 | 2018 |
| National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality E Voskaridou, A Kattamis, C Fragodimitri, A Kourakli, P Chalkia, ... Annals of hematology 98, 55-66, 2019 | 61 | 2019 |
| Relationship between Helicobacter pylori infection and multiple sclerosis E Gavalas, J Kountouras, M Boziki, C Zavos, SA Polyzos, E Vlachaki, ... Annals of gastroenterology: quarterly publication of the Hellenic Society of …, 2015 | 60 | 2015 |
| Beta-thalassemia: renal complications and mechanisms: a narrative review C Demosthenous, E Vlachaki, C Apostolou, P Eleftheriou, A Kotsiafti, ... Hematology 24 (1), 426-438, 2019 | 57 | 2019 |
| Comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with … V Perifanis, A Christoforidis, E Vlachaki, I Tsatra, G Spanos, ... International journal of hematology 86 (5), 385-389, 2007 | 44 | 2007 |
| In vivo HSC prime editing rescues sickle cell disease in a mouse model C Li, A Georgakopoulou, GA Newby, PJ Chen, KA Everette, K Paschoudi, ... Blood, The Journal of the American Society of Hematology 141 (17), 2085-2099, 2023 | 36 | 2023 |
| Pure red cell aplasia and lymphoproliferative disorders: an infrequent association E Vlachaki, MD Diamantidis, P Klonizakis, S Haralambidou-Vranitsa, ... The scientific world journal 2012, 2012 | 35 | 2012 |
| In vitro evidence of complement activation in patients with sickle cell disease E Gavriilaki, M Mainou, I Christodoulou, EE Koravou, A Paleta, ... Haematologica 102 (12), e481, 2017 | 34 | 2017 |
| Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia KM Musallam, A Vitrano, A Meloni, SA Pollina, M Karimi, A El-Beshlawy, ... Haematologica 106 (9), 2489, 2021 | 31 | 2021 |
| Successful outcome of hyperhemolysis in sickle cell disease following multiple lines of treatment: the role of complement inhibition E Vlachaki, E Gavriilaki, K Kafantari, D Adamidou, D Tsitsikas, ... Hemoglobin 42 (5-6), 339-341, 2018 | 30 | 2018 |
| Treatment of chronic hepatitis C with direct‐acting antivirals in patients with β‐thalassaemia major and advanced liver disease E Sinakos, D Kountouras, J Koskinas, K Zachou, S Karatapanis, ... British Journal of Haematology 178 (1), 130-136, 2017 | 29 | 2017 |
| Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic? MD Diamantidis, N Neokleous, A Agapidou, E Vetsiou, A Manafas, ... International journal of hematology 103, 537-544, 2016 | 28 | 2016 |
| Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia KM Musallam, A Vitrano, A Meloni, SA Pollina, M Karimi, A El-Beshlawy, ... American journal of hematology 97 (2), E78-E80, 2022 | 26 | 2022 |
| Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review A Daniilidis, N Panteleris, E Vlachaki, C Breymann, E Assimakopoulos Journal of Obstetrics and Gynaecology 38 (4), 443-447, 2018 | 25 | 2018 |
| Pulmonary and myocardial manifestations due to Toxocara canis infection S Haralambidou, E Vlachaki, E Ioannidou, V Milioni, S Haralambidis, ... European Journal of Internal Medicine 16 (8), 601-602, 2005 | 25 | 2005 |
| Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing A Tampaki, E Gavriilaki, C Varelas, A Anagnostopoulos, E Vlachaki Blood Reviews 48, 100805, 2021 | 21 | 2021 |
| The BELIEVE trial: results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept in adult beta-thalassemia patients who require regular red blood … MD Cappellini, V Viprakasit, A Taher, P Georgiev, KHM Kuo, TD Coates, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 21 | 2018 |
| Haematoma caused by bone marrow aspiration and trephine biopsy M Sarigianni, E Vlachaki, S Chissan, F Klonizakis, E Vetsiou, ... Hematology reports 3 (3), e25, 2011 | 21 | 2011 |
